Zobrazeno 1 - 7
of 7
pro vyhledávání: '"NAGASAMY VENKATESH DHANDAPANI"'
Autor:
Veera Venkata Satyanarayana Reddy Karri, Nagasamy Venkatesh Dhandapani, Sai Sandeep Mannemala, Kollipara Radhakrishna, Shashank Mulukutla, Dedeepya Sudunagunta
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 53, Iss 2 (2017)
Abstract Lenalidomide (LND) is an anti-cancer drug and an effective derivative of thalidomide used for multiple myeloma therapy. Because of its poor solubility in water, LND is known to cause low oral bioavailability (below 33%), and as a direct cons
Externí odkaz:
https://doaj.org/article/5ccec5d543c24916bfae5b45e5e1e3ea
Publikováno v:
All Results Journals: Biol, Vol 3, Iss 2, Pp 10-23 (2012)
Oral multiparticulate drug system (e.g. pellets, granules) in comparison to single unit dosage form offer biopharmaceutical advantages in terms of more even and predictable drug distribution in enteric system. Extrusion spheronization is one of the m
Externí odkaz:
https://doaj.org/article/7d13956bdbda4ccbb84cb2006db06ff9
Cefixime, a BCS class II drug, is insoluble in water but freely soluble in acetone and in alcohol. The aqueous solubility of cefixime in water is poor and exhibits exceptionally slow and intrinsic dissolution rate. In the present study, cefixime and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8572fb684cfc260c16e7d33cd18cff
The objective of the present study was to develop sustained release oral matrix tablets of anti epileptic drug levetiracetam. The sustained release matrix tablets of levetiracetam were prepared using hydrophilic matrix hydroxypropyl methylcellulose (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b150b899dfc46e1a33b63ec4167a180f
Autor:
Sai Sandeep Mannemala, Dedeepya Sudunagunta, Nagasamy Venkatesh Dhandapani, Shashank Mulukutla, Veera Venkata Satyanarayana Reddy Karri, Kollipara Radhakrishna
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences; Vol. 53 No. 2 (2017); e15185
Brazilian Journal of Pharmaceutical Sciences; Vol. 53 Núm. 2 (2017); e15185
Brazilian Journal of Pharmaceutical Sciences; v. 53 n. 2 (2017); e15185
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Pharmaceutical Sciences, Vol 53, Iss 2 (2017)
Brazilian Journal of Pharmaceutical Sciences, Volume: 53, Issue: 2, Article number: e15185, Published: 22 JUN 2017
Brazilian Journal of Pharmaceutical Sciences; Vol. 53 Núm. 2 (2017); e15185
Brazilian Journal of Pharmaceutical Sciences; v. 53 n. 2 (2017); e15185
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Pharmaceutical Sciences, Vol 53, Iss 2 (2017)
Brazilian Journal of Pharmaceutical Sciences, Volume: 53, Issue: 2, Article number: e15185, Published: 22 JUN 2017
Lenalidomide (LND) is an anti-cancer drug and an effective derivative of thalidomide used for multiple myeloma therapy. Because of its poor solubility in water, LND is known to cause low oral bioavailability (below 33%), and as a direct consequence o
Publikováno v:
Chronicles of Young Scientists, Vol 2, Iss 4, Pp 192-196 (2011)
Alginate and chitosan are commonly used polymers in modifying the drug release. These two polymers can be used together or separately to form drug loaded modified release beads. The ionotropic gelation method and a slight modification in various ways
Autor:
Kammari Harish Kumar, Himangshu Bhowmik, Anuttam Kuila, Abhishek Soni, Nagasamy Venkatesh Dhandapani
Publikováno v:
Asian Journal of Pharmaceutical and Clinical Research. 11:15
The research on chronotherapy has garnered interest from scientists to understand circadian rhythms and their applications in the biological system. The area of chronotherapeutics covers essential information which is helpful to move forward and solv